CKMB
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- COBAS
- Commercial name
- 19-092 IVD Assay Reagents/Kits, Immunoassay, Cardiac Marker
- Analysis ID
- d41e83a1dbe4305807bdfca967d54672
- Registration date
- August 10, 2023
- Expiration date
- August 10, 2028
- City
- MANNHEIM
- Country
- GERMANY
- Address
- SANDHOFER STR. 116, 68305 MANNHEIM
- Name
- ROCHE DIAGNOSTICS GMBH
- Country
- GERMANY
- Address
- AV SIMON BOLIVAR N/A Y VIA A NAYON
- Phone
- 3997100
QUANTITATIVE DETERMINATION OF THE CATALYTIC ACTIVITY OF THE CREATINE KINASE MB SUBUNIT (CK-MB) IN HUMAN SERUM AND PLASMA.
Access comprehensive regulatory information for CKMB in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID d41e83a1dbe4305807bdfca967d54672 and manufactured by ROCHE DIAGNOSTICS GMBH. The device was registered on August 10, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.